ERcast: Clinical Perspectives Podcast Preview
The summary below is from an episode of ERcast: Clinical Perspectives
Septic shock is common, but the dangerous miss is treating the bundle while missing the source or the mimic. Early appropriate antibiotics matter in unstable patients, source control matters more than any single drug choice, and hypotension is not automatically sepsis.
Septic Shock Pearls and Pitfalls
- Early appropriate antibiotics: In septic shock, each hour of delay after hypotension begins is linked to about an 8% rise in mortality, so unstable patients need broad appropriate coverage up front.
- Therapeutic momentum risk: What gets started in the ED often persists in the ICU, so the first antimicrobial choice has outsized consequences for coverage, culture interpretation, and downstream source control.
- Premature closure bias: A plausible shock diagnosis like CHF, STEMI, GI bleed, or PE does not exclude bacteremia; if sepsis is in play, get cultures and start antibiotics early because they can be narrowed or stopped later.
- Source control priority: Bacteremia starts somewhere, and the highest-yield sepsis question is where the infection began; when the source is not obvious, the stepwise search strategy is worth hearing in the episode.
- Risk-tailored empiric therapy: Prior culture data should change front-end treatment: a history of ESBL pushes toward a carbapenem, and prior fungemia should raise early antifungal coverage.
- Shock mimic red flags: Hypotension with bradycardia is not typical septic physiology, and every hypotensive patient deserves a broader screen for STEMI, myocarditis, hemorrhage, PE, pancreatitis, and toxicologic mimics.
Finding the Source of Bacteremia
- Common source checkpoints: Start with the basics: urine, chest, and indwelling hardware, because pneumonia, urinary infection, and line-related infection still account for many septic presentations.
- Occult abdominal sources: Worsening shock despite fluids and antibiotics should raise concern for biliary sepsis, acalculous cholecystitis, intra-abdominal infection, or obstructing pyelonephritis.
- Skin and soft tissue exam: Necrotizing soft tissue infection and Fournier gangrene are easy to miss if you do not look, making a full skin exam part of source control rather than an optional extra.
- Meningitis treatment timing: If meningitis or encephalitis is a real concern, start antibiotics first; CSF cultures may sterilize, but cell counts typically still show the inflammatory pattern.
- Indwelling line approach: A suspected infected central line should not be used, but routine line cultures create false positives from colonization; the bedside line strategy has useful nuance in the chapter.
- Host risk factor clues: Frequent hospitalizations, immunosuppression, biliary stents, prior obstructing stones, and recent resistant organisms all sharpen both source suspicion and empiric coverage.
Subscribe to ERcast: Clinical Perspectives to listen to the episode.
References:
- S Kumar A, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006 Jun;34(6):1589-96. PMID:16625125.
Faculty
- Matthew DeLaney, MD, FACEP, FAAEM
Dr. Matthew DeLaney is an emergency medicine physician and educator based in Birmingham, Alabama. A native of Mobile, he earned his medical degree from the University of South Alabama and completed his emergency medicine residency at Maine Medical Center.Dr. DeLaney has experience in both community and academic emergency medicine and is known for his commitment to teaching and medical education. He lives in Birmingham with his wife, Erin, who is also a physician, and their two daughters.
- David Page MD, MSPH